Amyloidosis is a uncommon illness of misfolded proteins that go astray to kind deposits of amyloid in organs, nerves and tissues. There are a number of differing types, however when sufficient amyloid builds up within the coronary heart, it causes coronary heart failure and signs equivalent to shortness of breath, fluid buildup and fainting. Patients can also have coronary heart rhythm issues and may want a pacemaker. Early prognosis is crucial as a result of, whereas amyloidosis is just not curable, it’s treatable with new medical therapies that may dramatically scale back the quantity of amyloid produced and cease illness development.
Using ECG-AI, clinicians at Mayo Clinic can doubtlessly flag sufferers who’re within the early levels of cardiac amyloidosis. The expertise is utilized in analysis and has FDA breakthrough machine designation.
"We’ve done some research indicating that, if we apply artificial intelligence just to the electrocardiogram, we can suggest if the patient has the diagnosis, often before a clinician has even suspected it. So we believe that this is a way to make an early diagnosis," says Martha Grogan, M.D., a heart specialist at Mayo Clinic in Rochester, Minnesota. "Now, it has to be put in clinical context. It’s not just that one AI ECG, but it can really help us suspect amyloidosis."
____________________________________________
FOR THE PUBLIC: More well being and medical information on the Mayo Clinic News Network. https://newsnetwork.mayoclinic.org/
FOR THE MEDIA ONLY: To entry clear and NAT sound variations of this video on the Mayo Clinic News Network, register at https://newsnetwork.mayoclinic.org/request-account/
Mayo Clinic: https://mayocl.in/3tNMAdF
Like Mayo Clinic on Facebook: https://www.facebook.com/MayoClinic
Follow Mayo Clinic on Instagram https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on X, previously Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic
